CervoMed
CRVO on Nasdaq. Market value $26m.
Should I look at this?
Look carefully before going further
Why it could be worth it
Nothing stands out yet.
What to watch out for
Read the warning sign in its own filings
This is not advice.
Who owns it
None of the long-term investors we follow own it. 37 funds in all.
Largest holders overall
- Woodline Partners LP$2mNew
- Vanguard Capital Management$980,226
- Sabby Management$771,528New
- Geode Capital Management$207,520Cut
- BlackRock$166,920Added
- Byrne Asset Management$158,875Added
- Citizens Financial Group$116,179
- Vanguard Fiduciary Trust$112,068
- Jane Street Group$99,916Added
- Thompson Davis$92,225Added
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
4 investors own more than 5%.
- BOGER JOSHUA SInsider or founder20.0%Since 11 June 2026
- Armistice Capital, LLCPassive investorat least 9.5%(filed with 1 related holder)Since 30 June 2026
- RA Capital Management, L.P.Passive investorat least 8.6%−1.3 pts(filed with 3 related holders)Since 30 June 2026
- Woodline Partners LPPassive investor5.1%Since 30 June 2026
- AWM Investment Company, Inc.Passive investorSold down below 5%Since 31 March 2026
- Morgan StanleyPassive investorSold down below 5%Since 30 June 2026
- CVI Investments, Inc.Passive investorSold down below 5%Since 30 June 2026
| Holder | Stake | Since | |
|---|---|---|---|
BOGER JOSHUA S Insider or founder | 20.0% | 11 June 2026 | |
Armistice Capital, LLC Passive investor | at least 9.5% (filed with 1 related holder) | 30 June 2026 | |
RA Capital Management, L.P. Passive investor | at least 8.6%−1.3 pts (filed with 3 related holders) | 30 June 2026 | |
Woodline Partners LP Passive investor | 5.1% | 30 June 2026 | |
AWM Investment Company, Inc. Passive investor | Sold down below 5% | 31 March 2026 | |
Morgan Stanley Passive investor | Sold down below 5% | 30 June 2026 | |
CVI Investments, Inc. Passive investor | Sold down below 5% | 30 June 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
In the last 12 months, 2 insiders bought $3m of shares on the open market.
- ALAM JOHN JCEO & President, DirectorBought
- Date
- 18 November 2026
- Shares
- 100,000
- Price
- $1.53
- Value
- $152,621
- BOGER JOSHUA SDirectorBought
- Date
- 11 June 2026
- Shares
- 955,414
- Price
- $3.14
- Value
- $3m
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 18 November 2026 | ALAM JOHN J CEO & President, Director | Bought | 100,000 | $1.53 | $152,621 |
| 11 June 2026 | BOGER JOSHUA S Director | Bought | 955,414 | $3.14 | $3m |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
1 serious warning sign in CervoMed’s filings.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 13 Mar 2026, plus the 10-Q filed 6 Nov 2026 and 24 later 8-Ks.
Doubt it can keep going
SeriousThe company or its auditor warned it may not have enough money to last the next year.
“These conditions cause substantial doubt regarding the Company’s ability to continue as a going concern.”
Show the full paragraph
The Company has $ 19.6 million of cash, cash equivalents, and marketable securities as of September 30, 2026, has generated negative cash flows from operations and had an accumulated deficit of $ 118.1 million as of September 30, 2026. The Company expects to continue to generate operating losses for the foreseeable future. The Company’s future viability is dependent on its ability to raise additional capital to finance its operations and pursue its business strategies. There can be no assurances that additional funding will be available on terms acceptable to the Company, or at all. These conditions cause substantial doubt regarding the Company’s ability to continue as a going concern.
From the 10-Q filed 6 November 2026, Part I, Item 1. Financial Statements. Read it in the filing
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.